|Articles|February 10, 2022

5 takeaways from 2021 Issue & Attitudes Survey

Here are 5 important takeaways from the annual survey.

In the fall of 2021, Contemporary Pediatrics fielded its annual survey to take the temperature on the practice of pediatrics and what's on the mind of clinicians. Here are 5 important takeaways from the results.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Subscribe

Related Content

RSV Diagnosis: Why Specific Testing Matters for RSV Management

ByFlor M. Munoz, MD, MSc,C. Buddy Creech, MD, MPH,Eric Simões, MD,Tina Q. Tan, MD, FAAP, FIDSA, FPIDS

June 8th 2026

RSV Clinical Presentation: Recognizing Severe Disease and Hospitalization Risk

ByFlor M. Munoz, MD, MSc,C. Buddy Creech, MD, MPH,Eric Simões, MD,Tina Q. Tan, MD, FAAP, FIDSA, FPIDS

June 8th 2026

RSV Risk Factors Across Age Groups: From Infants to Older Adults

ByFlor M. Munoz, MD, MSc,C. Buddy Creech, MD, MPH,Eric Simões, MD,Tina Q. Tan, MD, FAAP, FIDSA, FPIDS

June 1st 2026

RSV Epidemiology: Understanding Regional Trends and At-Risk Pediatric Populations

ByFlor M. Munoz, MD, MSc,C. Buddy Creech, MD, MPH,Eric Simões, MD,Tina Q. Tan, MD, FAAP, FIDSA, FPIDS

June 1st 2026

Arcutis submits sNDA for roflumilast cream 0.05% in atopic dermatitis for infants down to 3 months

Arcutis submits sNDA for roflumilast cream 0.05% in atopic dermatitis for infants as young as 3 months

ByPatrick Campbell

April 27th 2026

Latest CME

Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

5 takeaways from 2021 Issue & Attitudes Survey

Related Content

RSV Diagnosis: Why Specific Testing Matters for RSV Management

RSV Clinical Presentation: Recognizing Severe Disease and Hospitalization Risk

RSV Risk Factors Across Age Groups: From Infants to Older Adults

RSV Epidemiology: Understanding Regional Trends and At-Risk Pediatric Populations

Arcutis submits sNDA for roflumilast cream 0.05% in atopic dermatitis for infants as young as 3 months

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Trending on Contemporary Pediatrics

Earlier egg introduction guidelines linked to measurable decline in infant egg allergy prevalence

ALYFTREK phase 3 data support pediatric CFTR modulator submissions

FDA expands marstacimab (HYMPAVZI) approval to children ages 6–11 and hemophilia patients with inhibitors

New evidence backs pediatric flu vaccination efficacy as CDC drops it from childhood schedule

FDA grants GEn-1123 rare disease designations for Duchenne muscular dystrophy